Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025, changes federal law or congressional policy affecting federal agencies and legislative administrators. The main policy domain is Government Operations, Healthcare, Education.
Who Benefits and How
federal agencies and legislative administrators may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section HC1FF584AE633454095078E0EEAFFC210: 1. Short title This Act may be cited as the Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
- Section H7FC693FD69F54F84A392734840654B2A: 2. Research on uterine fibroid early detection and intervention The Secretary of Health and Human Services (referred to in this Act as the Secretary) shall—...
- Section H5C3EAE3578784812B054FEE771D21012: 3. Grants with respect to uterine fibroid early detection and intervention The Secretary may award grants to States for carrying out programs— to increase...
- Section H165B91D718A24C72A1CB0D69EC99A42E: 4. Research with respect to uterine fibroid early detection and intervention The Secretary may award grants to States for the purpose of conducting research,...
- Section HEBCF66B151EF4878A027E78AACB9A9C5: 5. Reports to Congress Not later 2 years after the initial award of grants under section 2 or 3, and every 2 years thereafter, the Secretary shall submit to...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025, changes federal law or congressional policy affecting federal agencies and legislative administrators.
Key Policy Areas
Government Operations, Healthcare, Education
Primary Purpose
This bill, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025, changes federal law or congressional policy affecting federal agencies and legislative administrators.
Policy Domains
Whole bill
Identified Gains
- federal agencies and legislative administrators
Identified Costs
- federal implementing agencies
Sponsors
Legislative Progress
In CommitteeCommittee on Health, Education, Labor, and Pensions. Hearings held.
Ms. Alsobrooks (for herself and Ms. Lummis) introduced the following …
Read twice and referred to the Committee on Health, Education, …
Introduced in Senate
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "secretary_of_health_and_human_services"
- → Secretary of Health and Human Services
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology